Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
2023 · Signal Transduction and Targeted Therapy · 266 citations
https://doi.org/10.1038/s41392-022-01235-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
444
Citations
8
h-index
8
i10-index
Xuya Zhao is an academic researcher from Guizhou Cancer Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 8, co-authored 17 publications.
https://doi.org/10.1038/s41392-022-01235-0
https://doi.org/10.1186/s12935-019-1023-7
https://doi.org/10.7314/apjcp.2015.16.14.6135
Click to start Chat